Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Philips Claims SoClean Ozone Emissions Increased Degradation of Toxic Foam Linked to CPAP Device Recall Ozone emissions, like those linked to SoClean devices, increased sound abatement foam degradation in recalled CPAP machines by a factor of 14, Philips claims July 19, 2022 Irvin Jackson Add Your Comments One year after a Philips CPAP device recall was issued for millions of sleep apnea machines that contained a defective sound abatement foam, the manufacturer has released a new report suggesting ozone emissions from SoClean cleaning machines may have been a factor in the rate at which the foam degraded and released toxic chemicals into the air pathways. The recalled CPAP machines were introduced in 2009, containing a polyester-based polyurethane (PE-PUR) foam, which was intended to reduce noise and vibrations while the devices were used at night. However, in June 2021, Philips Respironics announced the massive recall, following widespread reports of foam degradation and small black particles being found in the CPAP tubing and face masks. Thousands of Philips CPAP lawsuits are already being pursued by former users diagnosed with various types of cancer, lung damage and other injuries, after breathing in the particles and gasses released by the degrading foam, alleging that the devices were defective and unreasonably dangerous. Stay Up-to-Date About Philips CPAP Recall Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments. "*" indicates required fields Email* Δ Learn More Stay Up-to-Date About Philips CPAP Recall Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments. "*" indicates required fields Email* Δ Learn More In a report (PDF) released by Philips on June 28, which could be seen as self-serving, the manufacturer released data on an analysis of more than 60,800 recalled devices, and claims that CPAP machines which went through repeated ozone cleanings with products like SoClean 2 were 14 times more likely to show visual signs of foam degradation. “While certain prolonged tests across the affected product categories are still to be completed, the results to date for the first-generation DreamStation devices, which represent the majority of the registered affected devices, show a very low prevalence of visible foam degradation,” Royal Philips CEO Frans van Houten said in the press release. “Results to date also indicate that ozone cleaning significantly exacerbates foam degradation.” SoClean Blamed for Increasing Foam Degradation SoClean devices have been marketed in recent years to help sterilize and deodorize CPAP breathing machines. However, to effectively clean the devices, SoClean uses ozone gas, which some lawsuit allege exceed levels which can be safely tolerated by humans or animals. Immediately after disclosing the problems with their sleep apnea machines last year, Philips attempted to blame the CPAP recall on SoClean, suggesting the use of ozone and UV light cleaning devices may exacerbate the foam’s degradation. However, in October 2021, SoClean sued Philips, arguing it was attempting to use the ozone cleaning machine as a scapegoat for what it called a “glaring design flaw” which placed a defective sound abatement foam directly in the machine’s air pathways. According to the recent report issued by Philips, the study included 36,341 devices where users reported no use of ozone cleaning, 11,309 devices where users confirmed they did use ozone cleaning and 13,197 devices where it was unknown. While the prevalence of visible foam degradation was only about 0.5% among owners who did not report using an ozone cleaning device, nearly 7% of devices with self-reported ozone use “showed significant visible foam degradation.” Safety Concerns from “Significant” CPAP Foam Degradation In a statement released together with the findings, Philips acknowledged that the foam particles were found within the air pathway of their devices, but attempted to suggest this accumulated debris was not necessarily being directly emitted into the mouths and lungs of users. “In those devices where visible foam degradation was significant, i.e. there was reduction in foam volume, it was observed that there was accumulation of degraded foam within the airpath inside the device. The foam becomes hygroscopic (i.e. absorbs moisture) and sticky with degradation. It also loses significant volume and increases density as the structure changes from a foam to viscous liquid material. As such, even when foam particles are formed by degradation, they are likely to accumulate within the device and may not be directly emitted by the device,” according to the statement. This directly contradicts thousands of reports submitted by users on social media and websites, describing “black sticky dust” or “black mold-like substance” inside the face mask and tubing of their machines, raising concerns about the long term side effects of breathing the CPAP foam particles. Lawsuits allege the Philips CPAP machines cause cancer and various other injuries following repeated exposure to the small particles night after night, as well breathing non-visible chemicals and gases the FDA indicates may be released by the polyester-based polyurethane foam. Given common questions of fact and law raised in complaints filed throughout the federal court system against Philips and SoClean, the litigation has been centralized before U.S. District Judge Joy Flowers Conti, in the Western District of Pennsylvania, for coordinated discovery and pretrial proceedings, where the parties are continuing to conduct independent discovery and intend to prepare a small group of “bellwether” cases for early trial dates to see how juries respond to certain evidence and testimony that will be repeated throughout the claims. Tags: Cancer, CPAP, CPAP Recall, Ozone, Philips, Respiratory, SoClean More Philips CPAP Recall Lawsuit Stories Lawsuits Between Philips and SoClean Over CPAP Machine Problems To Be Trial Ready by July 2025 September 3, 2024 Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October July 11, 2024 Philips OmniLab Advanced+ Ventilator Recall Issued Over Loss of Therapy Risks July 1, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
Lawsuits Between Philips and SoClean Over CPAP Machine Problems To Be Trial Ready by July 2025 September 3, 2024
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)